/PRNewswire/ -- At the 2026 JP Morgan Healthcare Conference, CytoReason unveiled LINA, an AI agent designed to support pharmaceutical research and development....
#Product Stage #Partners #Investment
/PRNewswire/ -- CytoReason, a leader in AI-powered computational disease modeling, today announced the expansion of its collaboration with Sanofi for the third...
#Partners #Investment
Israeli AI disease models co CytoReason raises $80m
#Investment #Partners #Expand
Momentum for Poolbeg and CytoReason's AI collaboration - PharmaTimes
#Partners
Sanofi extends cooperation with Israel's CytoReason for bowel disease drug discovery
#Partners
CytoReason raises $20 million from Pfizer for AI drug discovery and development platform | CTech
#Partners #Investment
CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus to Leverage Machine Learning in Drug Development for Korean Drugmakers
#Partners
Pfizer extends cooperation deal with Israeli AI drug development firm CytoReason
#Partners
סייטוריזן פיתחה תוכנת AI המנבאת הצלחה של ניסויים קליניים - Techtime - חדשות אלקטרוניקה והייטק
#Investment
Merck KGaA taps CytoReason's machine learning platform to profile immuno-oncology drug
undefined
CytoReason, Summit tap into AI on Japanese drug development effort
#Partners
CytoReason enters Japanese market with SPI partnership
#Partners
CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms
#Partners
CytoReason Announces Collaboration with Ferring to Identify Novel Therapeutic Targets in Inflammatory Bowel Disease Using AI Technology
#Partners
The secret Israeli sauce in Pfizer's new drug mix - Sponsored Content The Times of Israel
#Partners
AI-Powered Drug Development in a Post-COVID World
undefined
When can computer models replace animal trials? - Drug Discovery and Development
#Customers
New Startup Helps Pfizer Create More Effective, Targeted Drugs For Patients - The Tennessee Tribune
#Partners
https://www.jpost.com/opinion/hillels-tech-corner-cytoreason-where-ai-meets-drug-development-631184
#Partners #Customers
סייטוריזון בנבחרת הסטארטאפים 2020 של TheMarker
#Investment
Ground Breaking New Methodology Published in Nature Medicine Uncovers the Missing Numbers to the Only Clock That Really Matters in the Body - Your Immune Age
#Investment
CytoReason teams with Pfizer on drug discovery
#Partners
CytoReason builds largest reference of immune-focused inter-cellular communications
#Customers
CytoReason uses AI to personalize drugs, opening the door to cancer treatments
#Partners #Customers
CytoReason Signs Collaboration Agreement with Pfizer Inc. To Utilize CytoReason's Machine Learning Model of the Immune System for Drug Discovery
#Partners